Bafna Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bafna Pharmaceuticals Limited generated cash of $94,848,000, which is more than the previous year. Cash used in financing activities reached the amount of -$8,454,000 last year. Net change in cash is therefore -$64,134,000.
Cash Flow
| 2010 | -5.94M | -31.68M | 35.72M |
|---|---|---|---|
| 2011 | -63.53M | -105.00M | 267.92M |
| 2012 | -96.01M | -309.19M | 310.60M |
| 2016 | 9.10M | -3.61M | -6.05M |
| 2018 | -70.47M | 379.69M | -306.28M |
| 2020 | -343.08M | 327.74M | 73.01M |
| 2021 | -136.08M | -53.45M | 122.79M |
| 2023 | 49.52M | -74.92M | 101.77M |
| 2024 | 94.84M | -150.53M | -8.45M |
BAFNAPH.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 78.10M | 1.73M | 84.80M | 27.13M | 26.57M | 27.70M | 119.25M | 18.41M | 20.31M |
Operating activities | |||||||||
Net income | 73.47M | 117.69M | 58.26M | -18.83M | -147.16M | -140.26M | 18.40M | 33.48M | 24.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 49.95M | 53.34M | 44.78M | 32.66M | 39.74M | 48.58M | 63.02M | 22.65M | 17.37M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -48.73M | -270.41M | -35.24M | 187.99M | 294.96M | 78.38M | 0 | 0 | 0 |
Inventories | -74.23M | -19.39M | -40.30M | -21.29M | 60.65M | -2.57M | -87.56M | -54.09M | -46.81M |
Accounts payable | 69.61M | 160.55M | -18.49M | -268.82M | 47.05M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 94.84M | 49.52M | -136.08M | -343.08M | -70.47M | 9.10M | -96.01M | -63.53M | -5.94M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -155.78M | -82.18M | -60.94M | -14.28M | -1.26M | -23.06M | -299.79M | -107.85M | -33.64M |
Acquisitions Net | 0 | 1.96M | 0 | 0 | 469.36M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -150.53M | -74.92M | -53.45M | 327.74M | 379.69M | -3.61M | -309.19M | -105.00M | -31.68M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 553.55M | 120M | 0 | 76.25M | 98.36M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 14.65M | 118.64M | -123.68M | -200.00M | -356.85M | 123.50M | 0 | 0 | 0 |
Cash used in financing activities | -8.45M | 101.77M | 122.79M | 73.01M | -306.28M | -6.05M | 310.60M | 267.92M | 35.72M |
Net Change In Cash | -64.13M | 76.37M | -66.76M | 57.67M | 2.93M | -564.08K | -94.60M | 99.38M | -1.90M |
Cash at end of period | 13.96M | 78.1M | 18.03M | 84.80M | 29.51M | 27.13M | 24.64M | 117.79M | 18.41M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |